On February 3, 2026, President Trump signed H.R.7148, the Consolidated Appropriations Act, 2026, into law. Section 6703 of the Act, ...

Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.

Investing.com -- Clearmind Medicine Inc. (NASDAQ:CMND) stock surged 10.2% and Polyrizon Ltd. (NASDAQ:PLRZ) shares rose 3% in ...

Reusable AI application models enable organizations to apply predictive insights across multiple customer scenarios.

Kor, opens new tab, a U.S.-based nutraceutical company focused on science-informed longevity formulations for vitality and ...

OYE Therapeutics, a clinical-stage biopharmaceutical company advancing novel therapies for perioperative, emergency and acute-care medicine, announced Monday, Feb. 2 that the U.S. Food and Drug ...

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

Scientific Innovation and Advanced R&D Capabilities China is a leader in the beauty industry thanks to its growing research ecosystem. Leading manufacturers have moved away from outsourcing production ...

China’s OEM manufacturing segment is at the forefront in terms of digital transformation, clean skin formulation, skin microbiome, eco-packaging and smart dispensing. Topfeel, a Chinese factory that ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

GUANGZHOU, GUANGDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- The global cosmetics industry is witnessing a ...